OmniScience enters PMS space with Buffett, Graham-style philosophy, aims to achieve Rs 1,000 cr AUM in 3 years

OmniScience Capital on Monday announced its entry into the fast-growing PMS (Portfolio Management Services) sector and unveiled plans to scale its assets under management (AUM) to Rs 250 crore in the first year and Rs 1,000 crore within three years. The company said its PMS suite will be designed for a broader base of sophisticated, research-oriented scientific investors.As part of the PMS launch, OmniScience introduced three different product categories viz. Omni Crest, Omni Inevitables and Omni Institutional. In the first category, the company will offer foundational strategies that leverage OmniScience’s expertise in alpha generation. In the second category, it will provide scientific exposure to India’s uncorrelated structural growth vectors, while in the third category, the company will offer scientifically designed tailor-made solutions for institutional investors.

The investment management company has gone live with 22 strategies that feature proprietary, demonstrative skin in the game, according to a press release.Of these, Omni Inevitables represents a major innovation, the release said.

The company’s entry into the PMS segment was inspired by the five-fold growth of the sector in the last five years.

OmniScience Capital, founded by a team of IITians, claims to specialize in scientific, research-led investing with Rs 1,000 crore in client assets. OmniScience says its wealth management philosophy is based on a scientific investment framework – inspired by legends like Benjamin Graham, Warren Buffett and Peter Lynch, but purposefully extends beyond their traditional approaches. OmniScience is proud of its vision to practice investment management as a performance-oriented profession, rather than an asset-accumulating business. The company’s first-principles Scientific Investing Framework, applied to assets of Rs 10 billion (1,000 crore) over multiple market cycles, has proven itself through customer satisfaction as evidenced by their continued commitment,” the company statement said.

“When performance leads, the ecosystem wins,” says Vikas V Gupta, CEO and Chief Investment Strategist at OmniScience Capital, claiming that the company has created a niche science investment ecosystem of science investors, science partners and the science managers.

The scientific investment approach, seeking safety to chase true alpha, goes beyond the typical style-based approach, in the PMS/AIF/MF industry, of growth, quality, value, momentum or size, all of which can be replicated with smart beta and masquerade as alpha in its own favorable cycle.

(Disclaimer: The recommendations, suggestions, views and opinions expressed by the experts are their own. These do not represent the views of The Economic Times.)